期刊文献+

糖尿病肾病发病机制的研究进展 被引量:9

原文传递
导出
摘要 糖尿病肾病(DN)是糖尿病的严重并发症,也是导致糖尿病患者致死、致残的主要原因之一。其主要临床特点为尿白蛋白排泄率逐年增加、肾功能减退至终末期肾病。既往研究认为,DN主要病理特征是肾小球细胞外基质堆积、系膜增宽、基底膜增厚、肾小球硬化及肾间质纤维化。然而这些因素仅能解释30%~50%的尿白蛋白排泄率和肾小球滤过率(GFR)的变化。近来研究发现,除糖代谢紊乱、血流动力学改变等传统机制外,足细胞病变、炎性反应、氧化应激、遗传易感因素等非传统机制在DN发病机制中也起着关键作用。
作者 朱祎 沈惠风
出处 《中国医师进修杂志》 2012年第10期68-70,共3页 Chinese Journal of Postgraduates of Medicine
  • 相关文献

参考文献21

  • 1Marshall SM. Recent advances in diabetic nephropathy. Clin Med, 2004,4( 3 ) : 277-282.
  • 2Dalla Vestra M, Masiero A, Roiter AM, et al. Is podocyte injuryrelevant in diabetic nephropathy? Studies in patients with type 2 diabetes. Diabetes, 2003, 52(4):1031-1035.
  • 3Miyauchi M, Toyoda M, Kobayashi K, et al. Hypertrophy and loss of podocytes in diabetic nephropathy. Intern Med, 2009, 48 ( 18 ) : 1615-1620.
  • 4Wolf G, Chen S, Ziyadeh FN. From the periphery of the glomerular capillary wall toward the center of disease: podocyte injury comes of age in diabetic nephropathy. Diabetes, 2005, 54(6) : 1626-1634.
  • 5Iglesis-de la Cruz MC, Ziyadeh FN, Isono M, et al. Effects of high glucose and TGF-betal on the expression of collagen 1V and vascular endothelial growth factor in mouse podocytes. Kidney Int, 2002,62(3):901-913.
  • 6de Vriese AS, Tihon RG, Elger M, et al. Antibodies against vascular endothelial growth factor improve early renal dysfunction in experimental diabetes. J Am Soc Nephrol, 2001, 12 (5) : 993- 1000.
  • 7Wendt TM, Tanji N, Guo J, et al. RAGE drives the development of glomerulosclerosis and implicates podocyte activation in the pathogenesis of diabetic nephropathy. Am J Pathol,2003,162(4) : 1123-1137.
  • 8Endlich N, Kress KR, Reiser J,et al. Podocytes respond to mechanical stress in vitro. J Am Soc Nephrol, 2001,12 ( 3 ) : 413- 422.
  • 9Wolf G, Ziyadeh FN. Cellular and molecular mechanisms of proteinuria in diabetic nephropathy. Nephron Physiol, 2007,106 (2) :26-31.
  • 10Mundel P, Shankland SJ. Podocyte biology and response to injury. J Am Soc Nephrol, 2002, 13(12) : 3005-3015.

二级参考文献18

  • 1Phillips AO, Baboolal K, Riley S, et al. Association of prolonged hyperglycemia with glomerular hypertrophy and renal basement membrane thickening in the Goto kakizaki model of morn - insuline - dependent diabetes mellitus. Am J Kidney Dis,2001,37(2) :400 - 410.
  • 2Lianos EA,Orphanos V,Cattell V,et al. Glomerular expression and cell origin of transforming growth factor - beta 1 in anti- glomerular basement membrance disease. Am J Med Sci, 1994,307(1) : 1 - 5.
  • 3Hibbs JB, Taintor RR, Vavrin Z, et al. Nitric oxide: A cytotoxic activated macrophage effector molecule. Biochem Biophys Res Commun, 1988,157(1 ) :87 - 94.
  • 4Tipping PG, Leong TW, Holdsworth SR, et al. Tumor necrosis factor production by glomerular macrophages in anti- glomerular basement membrance glomerulonephritis in rabbits. Lab Inves, 1991,65(3) :272 - 279.
  • 5Nikolic - Paterson DJ, Atkins RC. The role of macrophage in glomerulonephritis. Nephrol Dial Transplant, 2001, 16(suppl 5 ) : 3 - 7.
  • 6Bohle A, Wehrmann M, Bogenschutz O, et al. The pathogenesis of chronic renal failure in diabetic nephropathy. Investigation of 488 cases of diabetic glomemlosclerosis. Pathology,Research & Pratice, 1991,3187(2 - 3) :251 - 259.
  • 7Utimura R, Fujihara CK, Mattar AL, et al. mycophenolate mofetil prevents the development of glomerular injury in experimental diabetes. Kidney Int, 2003,63(1) : 209 - 216.
  • 8Chow F,Ozols E, Nikolic - Paterson DJ, et al. Macrophages in mouse type 2 diabetic nephropathy: correlation with diabetic state and progressive renal injury. Kidney Int, 2004,65(1):116- 128.
  • 9Ihm CG, Park JK, Hong SP, et al. A high glucose concentration stimulates the expression of monocyte chemotactic peptide- 1 in human messangial cells. Nepheon, 1998, 79(1):33-37.
  • 10Suda T, Osajima A, Tamara M, et al. Pressure - induced expeession of monocyte chemottactant protein - 1 through activation of MAP kinase . Kidney Int, 2001,60(5) : 1705 -1715.

共引文献14

同被引文献82

引证文献9

二级引证文献136

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部